Evidence map›Paper›PMID 41723571›Full record

ArticleGut microbes2026

The role of gut microbes in production of aromatic carboxaldehydes.

Manish Kumar, Rachel Son, Sarah M Preston, Robert W P Glowacki, Kelley M Carr, Jiyeon Kim, Jin Z Ma, Philip P Ahern, Jan Claesen, Naseer Sangwan and 2 more

Abstract read
In one paragraph

Article in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Manish KumarDepartment of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland, OH, USA.ORCID 0000-0003-0955-191X
Rachel SonDepartment of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland, OH, USA.ORCID 0009-0007-6424-0846
Sarah M PrestonDepartment of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland, OH, USA.ORCID 0000-0002-5883-6789
Robert W P GlowackiDepartment of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland, OH, USA.ORCID 0000-0001-7718-5056
Kelley M CarrDepartment of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland, OH, USA.ORCID 0000-0002-0397-4551
Jiyeon KimDepartment of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland, OH, USA.ORCID 0000-0002-4849-8253
Jin Z MaDepartment of Inflammation & Immunity, Cleveland Clinic Research, Cleveland, OH, USA.
Philip P AhernDepartment of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland, OH, USA.ORCID 0000-0002-2083-3224
Jan ClaesenDepartment of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland, OH, USA.ORCID 0000-0002-0755-7974
Naseer SangwanDepartment of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland, OH, USA.ORCID 0000-0002-2407-769X
Florian RiederCenter for Microbiome & Human Health, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0002-9087-1568
Ina NemetDepartment of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland, OH, USA.ORCID 0000-0002-0657-7121

Funding

Septins in intestinal fibrosisR01DK132038 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI Andrei Ivanovich Ivanov, Florian Rieder · 2023 to 2026
$2.5M
Unraveling strain-level variation in the induction of anti-inflammatory responses in the intestineR01DK126772 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI AHERN, PHILIP PATRICK · 2021 to 2025
$2.4M
Gut-microbial metabolism of aromatic amino acids and cardiovascular diseaseR01HL160747 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI NEMET, INA · 2022 to 2025
$2.2M
Uncovering aryl polyene biology to identify new drug targets in Gram-negative bacterial pathogensR01AI153173 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI CLAESEN, JAN · 2021 to 2025
$2.0M
Creeping fat and Crohn's disease associated stricturesR01DK123233 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI RIEDER, FLORIAN · 2020 to 2024
$1.9M
NHLBI NIH HHS R01 HL160747NIAID NIH HHS R01 AI153173NIDDK NIH HHS R01 DK123233NIDDK NIH HHS R01 DK126772NIDDK NIH HHS R01 DK132038
6 · The paper itself

Abstract

Gut microbes play an important role in maintaining our health through the alteration of available nutrients and by the production of small molecules/metabolites. Indole-3-carboxaldehyde (I3A) is an aromatic carboxaldehyde (ArA) synthesized by gut microbes from the aromatic amino acid tryptophan, and has been mechanistically linked to antitumor activity, intestinal homeostasis, and metabolic syndrome. However, the capacity of gut microbes to produce other ArAs and their associations with host health remains largely unexplored due to a lack of methods for their detection and quantification. A stable isotope dilution mass spectrometry method for quantifying ArAs from all four aromatic amino acids (benzaldehyde (BA), 4-hydroxybenzaldehyde (4HBA), and 4-imidazolecarboxaldehyde (4IA) in addition to I3A) based on derivatization with 3-methoxyphenylhydrazine was developed and validated. Fecal levels of I3A and 4HBA were reduced in both human and mouse feces after a cocktail of nonabsorbable antibiotics depleted the gut microbiota, while the same treatment reduced BA in humans and 4IA in mice. Further, we identified multiple commensals with the capacity to produce selected ArAs in culture and showed that individuals with Crohn's disease, but not in those with ulcerative colitis, have lower fecal levels of I3A and 4HBA, relative to non-inflammatory bowel disease controls.

Indexed as

AldehydesBacteriaGastrointestinal MicrobiomeIndolesAmino Acids, AromaticAnimalsBenzaldehydesFecesHumansMass SpectrometryMice4-hydroxybenzaldehydeAldehydesAmino Acids, AromaticbenzaldehydeBenzaldehydesindole-3-carbaldehydeIndoles4-hydroxybenzaldehyde4-imidazolecarboxaldehydearomatic amino acidsaromatic carboxaldehydesbenzaldehydeCrohn's diseaseGut microbesIBDindole-3-carboxaldehydeinflammatory bowel diseaseulcerative colitis

Identifiers

PMID41723571
PMCPMC12928648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.